(Q39982691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Murray Krahn

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Q Yi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

E J Heathcote

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

27 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

802-813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C compensation may be extended

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01136.X

Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01136.X

Indications for interferon/ribavirin therapy in hepatitis C patients: findings from a survey of Canadian hepatologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01136.X

Discussing hidden bias in observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01136.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01136.X

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01136.X

10.1111/J.1365-2893.2009.01136.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19413692%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference